XML 33 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cash, Cash Equivalents, and Short-Term Investments
12 Months Ended
Dec. 31, 2023
Cash and Cash Equivalents [Abstract]  
Cash, Cash Equivalents, and Short-Term Investments CASH AND CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS:
December 31,
20232022
Cash and Cash Equivalents$199,371 $273,070 
Restricted Cash - Current(1)
43,897 40,366 
Restricted Cash - Non-current(1)
— 13,516 
Cash and Cash Equivalents and Restricted Cash$243,268 $326,952 
(1) Restricted Cash - Current is included in Other Current Assets in the accompanying Consolidated Balance Sheets. Restricted Cash - Non-current is included in Other Noncurrent Assets, net in the accompanying Consolidated Balance Sheets.
During the year ended December 31, 2023, the Company invested in marketable debt securities, primarily comprised of highly liquid U.S. Treasury securities. The investments are held in the custody of financial institutions. These securities are classified as available-for-sale securities and have maturity dates ranging from January 2024 through December 2024, and are classified as current assets accordingly.
The Company's investments in available-for-sale securities are as follows:
December 31, 2023
Gross Unrealized
Amortized CostAllowance for Credit LossesGainsLossesFair Value
U.S. Treasury Securities$81,829 $— $103 $— $81,932 
Available-for-sale investments are reported at fair value and any unrealized gains or losses are recognized in other comprehensive income, net of tax. The unrealized gains in the Company's portfolio at December 31, 2023 are the result of normal market fluctuations. Interest and dividends are included in net income when earned.